Welcome to our dedicated page for Kindly Md SEC filings (Ticker: NAKA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Kindly Md's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Kindly Md's regulatory disclosures and financial reporting.
Kindly MD, Inc. filed an 8-K reporting current beneficial ownership information for its common stock and tradeable warrants. The filing lists individual holdings for directors and executive officers and aggregates that all officers and directors as a group hold 21,798,017 shares, representing 5.80% of the outstanding common stock. It also discloses a significant institutional holder, Verition Multi-Strategy Master Fund Ltd., owning 37,781,847 shares, equal to 9.99% of the company. The filing is a routine ownership disclosure showing insider positions and a near-10% outside stake, without other transaction, financial performance, or management-change detail.
Kindly MD, Inc. (NAKA) filed an S-3ASR describing securities offerings, post鈥憁erger capital changes and risk factors. The filing discloses the company may use proceeds for a Bitcoin Treasury Strategy, working capital, debt repayment, acquisitions, capital expenditures, projects or share repurchases. It lists detailed terms that may govern future debt securities, warrants, rights and units. The company warns of costs and potential litigation from the Merger, post鈥慶losing volatility in its stock, future dilution from outstanding warrants, a convertible debenture and PIPE issuances, operational and regulatory risks (including implementing a bitcoin treasury operation and crypto regulation risks), and cyber and IP risks. The Registrant states its common stock trades on Nasdaq under NAKA and references recent SEC filings and exhibits that update its capital stock description.
Kindly MD, Inc. filed an amended Current Report (Form 8-K/A) that attaches exhibit-level disclosures for Nakamoto Holdings, Inc. The filing identifies the company's trading symbols as NAKA on The Nasdaq Stock Market LLC and NAKAW on the OTC Pink Market. It includes the consent of Wolf & Company, P.C., audited financial statements of Nakamoto as of April 30, 2025 and for the period from March 6, 2025 (inception) to April 30, 2025, unaudited financials as of June 30, 2025, unaudited pro forma condensed combined financial statements reflecting the acquisition of Nakamoto, supplemental risk factors, and management discussion and analysis for the stated periods. The filing is executed by CEO David Bailey.
Tyler Matthew Evans, identified as Chief Investment Officer and a director of Kindly MD, Inc. (NAKA), reported on Form 4 that on 08/14/2025 he acquired 2,232,114 shares of the issuer鈥檚 common stock at a reported price of $0, increasing his total beneficial ownership to 2,410,685 shares. The filing is signed on 08/22/2025. The form shows a non-derivative acquisition only and provides no additional explanatory detail about the mechanics or consideration for the transaction.
Kindly MD, Inc. (NAKA) Form 3: Tyler Matthew Evans filed an initial Form 3 disclosing direct beneficial ownership of 178,571 shares of Kindly MD common stock. The filing lists Evans as a Director, an Officer (Chief Investment Officer), and not a 10% owner. The Form 3 reports the event date of 08/14/2025 and is signed on 08/22/2025.
The filing reports that Andrew Creighton, serving as Chief Compliance Officer and a director of Kindly MD, Inc. (ticker: NAKA), executed a transaction on 08/14/2025 acquiring 2,232,114 shares of the issuer's common stock at a reported price of $0. Following the reported acquisition, Mr. Creighton beneficially owns 3,124,971 shares. The Form 4 was signed by Mr. Creighton on 08/19/2025. No derivative securities were reported on this form and no additional explanatory text about the nature of the $0 price was provided in the filing.
Kindly MD, Inc. (NAKA) reporting person Andrew Creighton disclosed direct beneficial ownership of 892,857 shares of common stock on a Form 3 filed for the 08/14/2025 event. The filing identifies Mr. Creighton as a director and as Chief Compliance Officer and is signed 08/19/2025. The Form 3 documents initial ownership and includes Exhibit 24 (Power of Attorney).
David F. Bailey, who is listed as both Chief Executive Officer and a Director of Kindly MD, Inc. (NAKA), reported a transaction dated 08/14/2025 on Form 4. The filing shows an acquisition of 11,160,572 shares of Common Stock at a reported price of $0. Following the transaction, Mr. Bailey is reported to beneficially own 11,160,572 shares in a direct ownership form. The Form 4 is signed by Mr. Bailey on 08/15/2025.
FAQ
What is the current stock price of Kindly Md (NAKA)?
What is the market cap of Kindly Md (NAKA)?
